Biotechnology

As biotechnology industry expands, so does the need for strategic marketing approaches to reach investors, regulatory bodies, healthcare providers, and consumers…read more

Biotechnology

The Future of Marketing in the Biotechnology Industry: The Role of Press Release Distribution

The biotechnology industry is experiencing rapid advancements in gene editing, personalized medicine, synthetic biology, and biopharmaceuticals. As the industry expands,…

Read More

Sonos, Inc. v. Google LLC: CAFC Leaves Expanded Role for Prosecution Laches in Limbo

The practice of serially filing continuation applications through a patent’s lifetime has come under increased pressure in recent years from…

Biotechnology

Federal Circuit Clarifies Limits of Issue Preclusion Between IPRs and District Courts

The Federal Circuit’s recent decision last week in Inland Diamond Prods. Co. v. Cherry Optical Inc., offers an important reminder…

Biotechnology

Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence

Patent eligibility under 35 U.S.C. § 101 should be a straightforward threshold question: any “new and useful process, machine, manufacture,…

Biotechnology

Stay Aware: Remote Employees Impact Venue Options In Patent Litigation

For many patent cases, the United States District Court hearing your patent dispute can have a big impact on case…

Biotechnology

Eye Therapies v. Slayback Pharma – Fed. Cir. Enhances the Scope of “Consisting Essentially” |

In Eye Therapeutics, LLC, v. Slayback Pharma, LLC., Appeal no. 2023-2173, (Fed. Cir., June 30, 2025), a panel of Judges…

Biotechnology

Federal Circuit Vacates $300 Million Verdict Against Apple, Orders Third Trial in LTE Patent Dispute

In a pivotal ruling for patent damages and standard-essential patent (SEP) litigation, the Federal Circuit vacated a $300 million award…

Biotechnology
Show More